Configurable vs Customizable Platforms and How to Choose the Right Approach for Your Study

Clinical trial protocols are becoming more complex than ever—driven by adaptive designs, biomarker-based decision-making, decentralized elements, and advanced therapies.

But while study designs have evolved, execution technology hasn’t always kept pace.

Many sponsors rely on configurable IRT/RTSM platforms designed for simpler workflows. As complexity increases, these systems can introduce operational constraints, limit flexibility, and create challenges when protocols inevitably change.

So how do you ensure your IRT strategy can support modern trials—without sacrificing speed or control?

This white paper explores:

• The difference between configurable and truly customizable IRT
• Why protocol complexity is reshaping execution requirements
• How customization can improve study resilience
• How AI is reducing the trade-off between flexibility and speed

Learn how to align your IRT strategy with the demands of modern clinical trials. Download the white paper below.